The identical KRAS mutation in both components of mucinous carcinoma and the mural nodules of anaplastic carcinoma provides additional evidence to support that some anaplastic mural nodules represent the dedifferentiation form of mucinous tumors in which p53 mutation may play crucial roles. This evidence concerns the gene KRAS and mucinous adenocarcinoma.